theory clinical_30_5
imports Main

begin

typedecl entity
typedecl event

consts
  Mutations :: "entity ⇒ bool"
  Activating :: "entity ⇒ bool"
  CTNNB1 :: "entity ⇒ bool"
  Proliferation :: "entity ⇒ bool"
  Cells :: "entity ⇒ bool"
  Promote :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Patient :: "event ⇒ entity ⇒ bool"
  Via :: "event ⇒ entity ⇒ bool"
  βCatenin :: "entity ⇒ bool"
  Inhibit :: "event ⇒ bool"
  Reduce :: "event ⇒ bool"
  Stop :: "event ⇒ bool"
  Cause :: "event ⇒ entity ⇒ bool"
  ReductionOrCessation :: "entity ⇒ bool"
  CrucialStep :: "entity ⇒ bool"
  Treat :: "event ⇒ bool"
  In :: "entity ⇒ entity ⇒ bool"
  Purpose :: "event ⇒ event ⇒ bool"
  EffectiveTreatment :: "event ⇒ bool"
  Through :: "event ⇒ event ⇒ bool"
  Address :: "event ⇒ bool"
  Directly :: "event ⇒ bool"
  Effective :: "event ⇒ bool"

(* Explanation 1: Activating mutations of CTNNB1 promote the proliferation of cells via β-catenin. *)
axiomatization where
  explanation_1: "∃x y z e. Mutations x ∧ Activating x ∧ CTNNB1 x ∧ Proliferation y ∧ Cells y ∧ Promote e ∧ Agent e x ∧ Patient e y ∧ Via e z ∧ βCatenin z"

(* Explanation 2: Inhibiting β-catenin can reduce or stop the proliferation of cells caused by activating mutations of CTNNB1, and this reduction or cessation is a crucial step in treating these mutations. *)
axiomatization where
  explanation_2_1: "∃x y z e1 e2. Inhibit e1 ∧ βCatenin x ∧ Agent e1 x ∧ Proliferation y ∧ Cells y ∧ (Reduce e2 ∨ Stop e2) ∧ Agent e2 x ∧ Patient e2 y ∧ Cause e2 z ∧ Mutations z ∧ Activating z ∧ CTNNB1 z"

axiomatization where
  explanation_2_2: "∃x y e1 e2. ReductionOrCessation x ∧ CrucialStep y ∧ Treat e1 ∧ Mutations y ∧ In x y ∧ Purpose e1 e2"

(* Explanation 3: Reducing or stopping the proliferation of cells through inhibiting β-catenin is considered an effective treatment for patients with activating CTNNB1 mutations, as it directly addresses the underlying cause of cell proliferation. *)
axiomatization where
  explanation_3_1: "∃x y z e1 e2 e3. (Reduce e1 ∨ Stop e1) ∧ Proliferation x ∧ Cells x ∧ Inhibit e2 ∧ βCatenin y ∧ Agent e2 y ∧ Through e1 e2 ∧ EffectiveTreatment e3 ∧ Patient e3 z ∧ Mutations z ∧ Activating z ∧ CTNNB1 z"

axiomatization where
  explanation_3_2: "∃x y e. Cause e x ∧ Proliferation y ∧ Cells y ∧ Address e ∧ Directly e ∧ Agent e x ∧ Patient e y"

theorem hypothesis:
  assumes asm: "βCatenin x ∧ Mutations y ∧ Activating y ∧ CTNNB1 y"
  (* Hypothesis: Inhibiting β-catenin may be effective in treating patients with activating CTNNB1 mutations *)
  shows "∃x y e1 e2. Inhibit e1 ∧ βCatenin x ∧ Agent e1 x ∧ Effective e2 ∧ Treat e2 ∧ Patient e2 y ∧ Mutations y ∧ Activating y ∧ CTNNB1 y"
proof -
  (* From the premise, we have known information about β-catenin and activating mutations of CTNNB1. *)
  from asm have "βCatenin x ∧ Mutations y ∧ Activating y ∧ CTNNB1 y" by blast
  (* We have a logical relation Implies(D, F), which states that inhibiting β-catenin leads to effective treatment for patients with activating CTNNB1 mutations. *)
  (* Explanation 2 provides that inhibiting β-catenin can reduce or stop the proliferation of cells caused by activating mutations of CTNNB1. *)
  (* Explanation 3 states that reducing or stopping the proliferation of cells through inhibiting β-catenin is considered an effective treatment. *)
  (* Therefore, we can infer that inhibiting β-catenin may be effective in treating patients with activating CTNNB1 mutations. *)
  then have "∃e1 e2. Inhibit e1 ∧ βCatenin x ∧ Agent e1 x ∧ Effective e2 ∧ Treat e2 ∧ Patient e2 y ∧ Mutations y ∧ Activating y ∧ CTNNB1 y" sledgehammer
  then show ?thesis <ATP>
qed

end
